AWMF-S2k-Leitlinie_ Chronischer Pruritus_ Version ... - Arztbibliothek

AWMF-Leitlinie chronischer Pruritus, Nr.: 013/048; Version 2.1 / 2011; Stand: 27.01.2011
108.Nettis E, Colanardi MC, Soccio AL, Ferrannini A, Vacca A. Desloratadine in combination
with montelukast suppresses the dermographometer challenge test papule, and is
effective in the treatment of delayed pressure urticaria: a randomized, double-blind,
placebo-controlled study. Br. J. Dermatol 2006: 155; 1279-1282
109.Nettis E, Colonardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with
montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebocontrolled
study. Clin. Exp. Allergy 2004: 34; 1401-1407
110.Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from
randomized, placebo-controlled clinical trials. Clin Ther 2003; 25: 81-104
111.Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations
and pain. Int J Dermatol 2003; 42: 491-495
112.Winhoven SM, Coulson IH, Bottomley WW. Brachioradial pruritus: response to treatment
with gabapentin. Br J Dermatol 2004; 150: 786-787
113.Bueller HA, Bernhard JD, Dubroff LM. Gabapentin treatment for brachioradial pruritus. J
Eur Acad Dermatol Venereol 1999; 13: 227-228
114.Schürmeyer-Horst F, Fischbach R, Nabavi D, Metze D, Ständer S. Brachioradialer
Pruritus: eine seltene, lokalisierte, neuropathische Juckreizform. Hautarzt 2006; 57: 523-
527
115.Loosemore MP, Bordeaux JS, Bernhard JD. Gabapentin treatment for notalgia
paresthetica, a common isolated peripheral sensory neuropathy. J Eur Acad Dermatol
Venereol 2007; 21: 1440-1441
116.Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for
pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial.
Nephrol Dial Transplant 2004; 19: 3137-3139
117.Naini AE, Harandi AA, Khanbabapour S et al. Gabapentin: a promising drug for the
treatment of uremic pruritus. Saudi J Kidney Dis Transpl 2007; 18: 378-381
118.Bergasa NV, McGee M, Ginsburg IH et al. Gabapentin in patients with the pruritus of
cholestasis: a double-blind, randomized, placebo-controlled trial. Hepatology 2006; 44:
1317-1323
119.Ehrchen J, Ständer S. Pregabalin in the treatment of chronic pruritus. JAAD 2008;
58: S36-S37
120.Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain
Symptom Manage 1998; 16: 121-124
121.Biondi M, Arcangeli T, Petrucci RM. Paroxetine in a case of psychogenic pruritus and
neurotic excoriations. Psychother Psychosom 2000; 69: 165-166
122.Tefferi A, Fonseca R. Selective serotonin reuptake inhibitors are effective in the
treatment of polycythemia vera-associated pruritus. Blood 2002; 99: 2627
123.Zylicz Z, Krajnik M, van Sorge AA, Constantini M. Paroxetine in the treatment of severe
non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage
2003; 26: 1105-1112
124.Mayo MJ, Handem I, Saldana S, Jacobe H, Getachew Y, Rush AJ. Sertraline as a firstline
treatment for cholestatic pruritus. Hepatology 2007. 45: 666-674
125.Ständer S, Böckenholt B, Schürmeyer-Horst F, Heuft G, Luger TA, Schneider G.
Treatment of Chronic Pruritus with the Selective Serotonin Re-uptake Inhibitors
Paroxetine and Fluvoxamine: Results of an open-labeled, two-arm Proof-of-concept
Study. Acta Derm Venereol. 2009; 89: 45-51
126.de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic
neurotransmission. Int Clin Psychopharmacol 1995; 10 (Suppl. 4): 19-23
127.Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S. Mirtazapine for pruritus. J Pain
Symptom Manage 2003; 25: 288-291
128.Hundley JJ, Yosipovitch G: Mirtazapine for reducing nocturnal itch in patients with
chronic pruritus: a pilot study. J Am Acad Dermatol 2004; 50: 889-891
129.Smith PF, Corelli RL. Doxepin in the management of pruritus associated with allergic
cutaneous reactions. Ann Pharmacother 1997; 31: 633-635
130.Smith KJ, Skelton HG, Yeager J, Lee RB, Wagner KF. Pruritus in HIV-1 disease: therapy
with drugs which may modulate the pattern of immune dysregulation. Dermatology 1997;
35